MIRANDA MERY: Open Payments
NPI 1447905914 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,119 in 139 payments from 20 companies in 2025. Trend: 2023 $2,195 · 2024 $2,603 · 2025 $3,119
Food & beverage: $3,119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $532 |
| Gilead Sciences, Inc. | 15 | $460 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $333 |
| PFIZER INC. | 11 | $239 |
| Ardelyx, Inc. | 21 | $236 |
| Madrigal Pharmaceuticals | 13 | $228 |
| Janssen Biotech, Inc. | 7 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $154 |
| Novo Nordisk Inc | 2 | $140 |
| QOL Medical, LLC | 3 | $114 |
Products named: XIFAXAN, IBSRELA, REZDIFFRA, RINVOQ, SKYRIZI, TREMFYA, ENTYVIO, Wegovy.
Industry payments across VA — which companies pay providers there.
